NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	Sepsis, Acute bronchitis, Pneumonia, Lung abscess, Pyothorax, Secondarinfection of chronic respiratory disease, Cystitis, Pyelonephritis, Cholecystitis, Cholangitis, Bartholinitis, Intrauterine infection, Uterine adnexitis, Parametritis, Purulent meningitisy
Date of first enrollment	14/12/2011
Target sample size
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : T-1220 INN of investigational material : Piperacillin Sodium Therapeutic category code : 613 Antibiotic preparations acting mainly on gram-positive, gram-negative bacteria Dosage and Administration for Investigational material : Intravenous drip

Outcome(s)

Primary Outcome	Efficacy and safety Same as above
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	>= 20age old
Age maximum	<= 15age old
Gender	Both
Include criteria	(1)Sex:male or female (2)Age: 20 years and older for adult and 28 days to 16 years old (inclusive) for child (3)Outpatient or inpatient: inpatient (4)Presence of definite symptom/findings of infectious disease (5)Others
Exclude criteria	(1)Medical history of allergy to any beta-lactam antibacterial agents. (2)Patient with infectious mononucleosis. (3)Pregnant females, females wishing to become pregnant or being possibly pregnant, and lactating females. (4)Others.